Core Viewpoint - The company has approved the continued use of raised funds to purchase financial products or structured deposits, aiming to enhance fund utilization efficiency while ensuring that it does not affect the construction of investment projects or the use of raised funds [2][14]. Summary by Sections Fundraising Overview - The company raised a total of 1,315,319,983.02 RMB through a non-public offering of 115,076,114 shares at a price of 11.43 RMB per share, with a net amount of 1,303,670,100.75 RMB after deducting various fees [2][4]. Fund Management - The company has established a special account for the management and storage of raised funds, ensuring that all funds are deposited in a board-approved special account and are subject to regulatory agreements with the sponsoring institution and the commercial bank [3]. Investment Projects - The company has adjusted its investment projects, reallocating funds from the "Health Industry Expansion Project" to invest 45,800.58 million RMB in the "Traditional Chinese Medicine Production Base Construction Project" [5]. Cash Management - The company plans to use up to 850 million RMB of idle raised funds for purchasing safe, liquid financial products or structured deposits with a capital preservation commitment, with the authority to make investment decisions granted to the chairman or CFO [10][14]. Risk Control Measures - The company will select financial products from issuers that can provide capital preservation guarantees, ensuring high safety and liquidity, and will not affect the normal operation of the investment projects [15][17]. Approval Process - The decision to continue using idle raised funds for financial products was approved by the board's audit committee and the board of directors, confirming compliance with relevant regulations and ensuring that it aligns with the interests of the company and its shareholders [13][18].

Core Viewpoint - The company plans to continue using up to RMB 500 million of temporarily idle raised funds for cash management, focusing on low-risk, high-liquidity investment products to enhance fund utilization efficiency and shareholder returns [2][18][49]. Fundraising Basic Situation - The company raised a total of RMB 1,081.49 million through the issuance of convertible bonds, with a net amount of RMB 1,069.04 million after deducting issuance costs [3]. - The funds have been deposited in a dedicated account for regulatory management to protect investor interests [3]. Fund Usage and Balance - As of June 30, 2025, the balance of the raised funds in the dedicated account was RMB 124.10 million [5]. - The company anticipates that some of the raised funds may remain idle for a certain period due to project progress [7]. Previous Cash Management Situation - In January 2025, the company approved the use of up to RMB 700 million of temporarily idle funds for cash management, investing in low-risk financial products [8]. - By October 2025, the company had utilized RMB 455 million for cash management, including structured deposits and large-denomination certificates of deposit [8]. Proposed Cash Management - The company aims to use up to RMB 500 million of temporarily idle funds for cash management to improve efficiency and reduce financial costs [9][10]. - The investment products will include high-safety, high-liquidity, and capital-protected financial products, with a maximum investment period of 12 months [11][12]. Approval Process - The board of directors held a temporary meeting on November 20-21, 2025, to approve the cash management proposal, which does not require shareholder meeting approval [18][49]. Impact on Daily Operations - The proposed cash management will not affect the normal operation of the company or the progress of fundraising projects, and it is expected to enhance overall performance and shareholder returns [17].

Core Viewpoint - Haicheng Bangda Supply Chain Management Co., Ltd. is facing a challenging financial situation with declining revenue and net profit, alongside low profit margins compared to industry averages [2][9]. Group 1: Financial Performance - For the first three quarters of this year, the company's revenue was approximately 6.529 billion yuan, a year-on-year decline of 13.74% [9]. - The net profit attributable to shareholders was 34 million yuan, down 59.15% year-on-year, while the net profit after deducting non-recurring items was 21 million yuan, a decrease of 73.37% [9]. - The gross margin stood at 6.33%, and the net margin was 0.48%, significantly lower than the industry median values of 12.96% and 3.88% respectively [2][9]. Group 2: Capital Actions - As of the end of October, the company had repurchased shares worth 40.1079 million yuan, acquiring 2,929,900 shares, which is 1.43% of the total share capital [3]. - The company plans to repurchase shares using 40 million to 80 million yuan of its own funds and loans, with a maximum repurchase price adjusted to 16.85 yuan per share [3]. - The company redeemed 110 million yuan of idle raised funds, recovering the principal and earning 536,300 yuan in interest from a structured deposit [3][4]. Group 3: Cash Management - The company has utilized 885 million yuan for cash management over the past 12 months, recovering 685 million yuan and earning a total of 2.9474 million yuan in returns [4]. - As of September 30, the cash balance was 963 million yuan, with the recent investment in financial products amounting to 150 million yuan, representing 15.58% of the latest cash balance [5]. Group 4: Project Progress - Since its IPO in 2021, only one of the three committed projects has been completed, with the remaining projects showing low investment progress [6]. - The "Logistics Network Expansion and Upgrade Project" has only progressed by 15.53%, while the "Supply Chain Information Technology Construction Project" has reached 24.81% [6][7]. - Adjustments have been made to the project timelines and investment structures to better align with business realities and external factors [7][8]. Group 5: Management Changes - A board member, Wang Xiping, plans to reduce his holdings by up to 198,400 shares, citing personal financial needs [8].

Core Viewpoint - The company plans to utilize up to 270 million yuan of temporarily idle raised funds for cash management, investing in safe principal-protected products such as structured deposits and large certificates of deposit [1] Group 1: Investment Details - The investment period is set from December 19, 2025, to April 30, 2026 [1] - The funds can be used on a rolling basis within the specified limit [1] Group 2: Impact on Operations - This decision will not affect the progress of the raised funds investment projects or the company's normal production and operations [1]

每经AI快讯，竞业达（SZ 003005，收盘价：21.48元）11月21日晚间发布公告称，公司第三届第十八次 董事会会议于2025年11月21日在公司会议室以现场方式召开。会议审议了《关于使用部分暂时闲置募集 资金进行现金管理的议案》等文件。 2025年1至6月份，竞业达的营业收入构成为：考试考务占比52.39%，城市轨道交通安防占比25.77%， 智慧教学占比21.78%，其他占比0.06%。 每经头条（nbdtoutiao）——展望"十五五" | 专访黄群慧：既要重视AI赋能千行百业，也要考量其对就业 的替代效应和带来的收入极化 （记者 王晓波） 截至发稿，竞业达市值为50亿元。 ...

证券代码：600313 证券简称：农发种业 公告编号：临2025-041 中农发种业集团股份有限公司 第七届董事会第五十四次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 中农发种业集团股份有限公司第七届董事会第五十四次会议于2025年11月20日以现场结合通讯方式召 开，会议通知和会议资料于2025年11月17日以微信及电子邮件形式发出。本次会议应出席董事6名，实 际参与表决董事6名，会议由董事长何才文先生主持，会议的召集及召开程序符合《公司法》、《公司 章程》的有关规定。 二、董事会会议审议情况 会议经审议通过了以下议案： （一）《关于聘任北京大地泰华会计师事务所（特殊普通合伙）为公司2025年度审计机构的议案》 表决结果： 6票赞成、 0 票反对、 0票弃权、 0票回避，议案通过。 公司拟继续聘任北京大地泰华会计师事务所（特殊普通合伙）负责本公司2025年度的审计工作，包括年 度财务报告审计及内部控制审计等，审计费用总计79万元。本议案已经公司董事会审计委员会审议通 过，全票同意继续 ...

Core Viewpoint - Zhejiang Yingtai Technology Co., Ltd. plans to utilize idle self-owned funds for cash management, with a total amount not exceeding 600 million RMB, to enhance fund efficiency and shareholder returns [1][2]. Cash Management Plan Key Points - The cash management will prioritize "safety and stability, liquidity first," mainly investing in low-risk financial products, including structured deposits, low-risk bank wealth management products, securities company income certificates, government bond reverse repos, and low-risk asset management products [2]. - The investment amount is capped at 600 million RMB, using idle self-owned funds, with a validity period of 12 months from the approval date by the shareholders' meeting [2]. - The board of directors will authorize management to make decisions within the limit, with the finance department responsible for implementation, and progress will be disclosed as per regulatory requirements [2]. Risk Control and Fund Security - The company has established multiple risk control measures despite focusing on low-risk products, including: 1. Dynamic monitoring mechanism to track product allocation and project progress [2]. 2. Term matching management to ensure liquidity based on operational funding plans [2]. 3. Internal audit supervision with regular checks on investment projects [2]. 4. Risk warning mechanism to prepare for market fluctuations and policy changes [2]. Impact on Company Operations - The cash management will not affect the normal operation of the main business and is expected to preserve and increase the value of idle funds [3]. - The investment amount represents a certain percentage of the latest audited net assets, ensuring safety and reasonableness in fund usage [3]. Review Procedures and Institutional Opinions - The proposal has been approved by the Audit Committee and the Board of Directors, with independent directors expressing agreement [4]. - The sponsor, Zheshang Securities, noted that the decision-making process for cash management is compliant and will enhance fund efficiency without harming shareholder interests [4]. Next Steps - The company will promptly convene a temporary shareholders' meeting to review the proposal, with relevant progress to be disclosed in a timely manner [5].

上海雅仕投资发展股份有限公司 第四届董事会第十三次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 二、董事会会议审议情况 本次董事会会议审议并通过了以下议案： (一)审议通过《关于增加募投项目实施主体并使用部分募集资金向新增实施主体提供借款以实施募投项 目议案》 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603329 证券简称：上海雅仕 公告编号：2025-074 一、董事会会议召开情况 上海雅仕投资发展股份有限公司（以下简称"公司"）第四届董事会第十三次会议于2025年11月19日在公 司会议室以现场结合通讯表决方式召开，会议通知及相关资料已于2025年11月14日以电子邮件方式发 出。本次会议应出席会议的董事9名，实际出席会议的董事9名，其中现场参会董事4名，以通讯表决方 式参会董事5名，部分高级管理人员列席会议，本次会议由董事长刘忠义先生主持。会议参与表决人数 及召集、召开程序符合《公司法》和《公司章程》的有关规定，所作决议合法有效。 同意公司新增全资子公司湖北雅仕实业控股有限公司作为募投 ...

Core Viewpoint - Chengda Pharmaceutical Co., Ltd. plans to utilize up to 700 million yuan of idle funds for low-risk cash management to enhance capital efficiency [1][5]. Group 1: Investment Plan - The investment will be limited to low-risk, highly liquid financial products with a maturity of no more than 12 months, including agreed deposits, notice deposits, time deposits, structured deposits, and financial institution wealth management products [2]. - The total investment limit for the company and its subsidiaries is set at 700 million yuan, which can be used cyclically within the 12-month period [2]. Group 2: Risk Control - The company has established multiple risk control mechanisms, including a dynamic tracking mechanism to monitor product allocation and project progress, internal audit supervision for regular checks on investment projects, and the option for third-party audits as needed [3]. Group 3: Impact on the Company - The cash management initiative aims to ensure normal operations and fund safety while achieving value preservation and appreciation of idle funds, ultimately creating more returns for shareholders [5]. - The 700 million yuan investment amount will be assessed against the company's latest audited cash reserves to ensure alignment with the principle of "standardized operation and prudent management" [5]. Group 4: Review Process and Sponsor Opinion - The proposal has been approved by the board's audit committee and will be submitted for shareholder approval [6]. - The sponsor, Guangda Securities Co., Ltd., has confirmed that the necessary review procedures were followed and has no objections to the cash management initiative [6].

Core Viewpoint - The company announced the recovery of 80 million yuan of raised funds from cash management products, yielding a profit of 932,600 yuan, which has been returned to the designated fund account [1] Group 1: Fund Management - The company plans to use 40 million yuan of idle raised funds to purchase structured deposit products from Bank of China, with a term of 60 days and an expected annual yield of 0.60% or 1.85% [1] - As of the announcement date, the company has a total of 125 million yuan in temporarily idle raised funds for cash management, including the current transaction [1]